Medicenna Therapeutics Corp logo

Medicenna Therapeutics Corp Share Price Today (NASDAQ: MDNA)

Medicenna Therapeutics Corp share price is $0 & ₹0.00 as on 31 Oct 2023 IST

▲

-0.16

(-100%)

Market is closed - opens 7 PM, 15 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 1 Nov 2023

View live Medicenna Therapeutics Corp share price in Dollar and Rupees. Guide to invest in Medicenna Therapeutics Corp stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Medicenna Therapeutics Corp, along with analyst recommendations, forecasts, and comprehensive financials.

Medicenna Therapeutics Corp (MDNA) Key Statistics

in dollars & INR

Previous Close
$0.157
Open
$0.1993
Market Capitalization
$11.2M
Today's Volume
$1.3M
Revenue TTM
$0.0
EBITDA
$-16.4M
Earnings Per Share (EPS)
$-0.09
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.0%

How to invest in Medicenna Therapeutics Corp Stock (MDNA) from India?

It is very easy for Indian residents to invest directly in Medicenna Therapeutics Corp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Medicenna Therapeutics Corp stock in both Indian Rupees (INR) and US Dollars (USD). Search for Medicenna Therapeutics Corp or MDNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Medicenna Therapeutics Corp or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Medicenna Therapeutics Corp shares which would translate to null fractional shares of Medicenna Therapeutics Corp as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Medicenna Therapeutics Corp, in just a few clicks!

Global Institutional Holdings in Medicenna Therapeutics Corp

    Analyst Recommendation on Medicenna Therapeutics Corp

    Rating
    Trend

    About Medicenna Therapeutics Corp

    Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
    Organization
    Medicenna Therapeutics Corp
    Employees
    16
    CEO
    Dr. Fahar Merchant Ph.D.
    Industry
    Health Technology

    Important FAQs about investing in MDNA Stock from India :

    Can Indians buy Medicenna Therapeutics Corp shares?

    Yes, Indians can invest in the Medicenna Therapeutics Corp (MDNA) from India.

    With INDmoney, you can buy Medicenna Therapeutics Corp at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Medicenna Therapeutics Corp at zero transaction cost.

    How can I buy Medicenna Therapeutics Corp shares from India?

    It is very easy to buy Medicenna Therapeutics Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Medicenna Therapeutics Corp (MDNA) be purchased?

    Yes, you can buy fractional shares of Medicenna Therapeutics Corp with INDmoney app.

    What are the documents required to start investing in Medicenna Therapeutics Corp stocks?

    To start investing in Medicenna Therapeutics Corp, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What is today's market capitalisation of Medicenna Therapeutics Corp?

    Today's market capitalisation of Medicenna Therapeutics Corp MDNA is 11.2M

    Who is the Chief Executive Officer (CEO) of Medicenna Therapeutics Corp ?

    Dr. Fahar Merchant Ph.D. is the current Chief Executive Officer (CEO) of Medicenna Therapeutics Corp.